Sponsor Check › Person
Named as an officer, director or promoter on SEC Form D filings · MA · Oct 8, 2009 → Jan 25, 2021
Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:20 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET
Mark Levin is listed as an executive officer and director on 23 SEC Form D filings by 9 issuers between Oct 2009 and Jan 2021. Largest by amount reported sold: Third Rock Ventures III, L.P. (Boston, MA — pooled investment fund — 2013; $500M reported sold to 58 investors), CONSTELLATION PHARMACEUTICALS INC (Cambridge, MA — biotechnology — 2010–2011; $99M reported sold to 30 investors), Fulcrum Therapeutics, Inc. (Cambridge, MA — biotechnology — 2016–2020; $80M reported sold to 20 investors), Voyager Therapeutics, Inc. (Lexington, MA — biotechnology — 2015; $60M reported sold to 10 investors), Foundation Medicine, Inc. (Cambridge, MA — biotechnology — 2010–2013; $56M reported sold to 22 investors) and 4 more (all listed below).
What this means A repeat sponsor — 9 separate companies raised money with this person listed as executive officer and director, over about 12 years. Across those companies the filings report $883.5M sold in total.
Listed alongside James Geraghty (6 shared filings), Robert Gould (5 shared filings), Robert Tepper (5 shared filings), Alan Ezekowitz (4 shared filings), David S. Celermajer (4 shared filings) and 58 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Mark. Each name links to their own page.
1 of the issuers belongs to the sponsor group Third Rock (7 issuers, $2.62B reported sold, 2010–2026).
What this means A sponsor group is one team that sets up a new company for each deal. Third Rock has 7 companies on file and $2.62B reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — 1 court case matching the name, 12 bankruptcy cases matching the name listed in Key records below.
What this means 13 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 23 public filings for Mark Levin and found 13 differences, 1 worth asking the sponsor about: Bankruptcy case: Mark M. Levin; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.
Community search for Mark Levin has not run yet — it is #6,156 of 48,144 in line; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.
Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.
Five things investors ask first. Items still in human review are counted, not shown.
1 case: 1 dismissed
190 Other contract actions
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:20 AM ET.
Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Mark Levin..
State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).
12 cases: 12 closed (disposition not in docket feed)
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:20 AM ET.
Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons cover issuers and sponsor groups — see the issuer pages under Deals
13 differences found between the filings for Mark Levin — 1 worth asking about (compared 23 filings on Oct 24, 2026)
United States Bankruptcy Court, D. Massachusetts docket "Mark M. Levin" filed Dec 3, 1990, closed May 15, 1991. Mark Levin is listed as Debtor ("Mark M. Levin"). Our match estimate: 44%.
What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.
United States Bankruptcy Court, E.D. New York docket "Chase Manhattan Bank USA NA v. Maniatis" filed May 14, 2001, closed Aug 15, 2001. TOM MANIATIS (listed on the same filings) is listed as Defendant ("Maniatis"). Our match estimate: 70%.
What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.
Third Rock Ventures II, L.P. (last filing Apr 9, 2010; $0 sold of $400,000,000). Each has no filing in more than two years and reported under half its target sold.
What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.
No amendment in the last 12 months on an offering that may still be open — Corvia Medical, Inc. (latest filing Jan 25, 2021) · No amendment in the last 12 months on an offering that may still be open — Fulcrum Therapeutics, Inc. (latest filing Jul 25, 2017) · No amendment in the last 12 months on an offering that may still be open — NinePoint Medical, Inc. (latest filing Nov 25, 2015) · No amendment in the last 12 months on an offering that may still be open — Voyager Therapeutics, Inc. (latest filing Apr 23, 2015) · No amendment in the last 12 months on an offering that may still be open — NinePoint Medical, Inc. (latest filing Mar 18, 2014) · and 4 more
What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.
The Oct 8, 2009 filing lists Mark Levin as executive officer, director; the Mar 18, 2014 Form D lists director.
What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.
The Sep 21, 2012 filing says $42,499,987 offered; the Jan 10, 2013 Form D/A says $55,962,423.
What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.
"No Revenues" (Apr 15, 2010); then "Decline to Disclose" (Aug 23, 2011).
What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.
This page covers filings where the address state is MA. A separate record, "Mark Levin" with address state NY, is listed on 1 filing — most recently by Hirshmark Capital REIT LLC (Dec 5, 2023). The two records do not overlap in time: this page runs Oct 8, 2009 to Jan 25, 2021; the other has one filing dated Dec 5, 2023.
What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is MA. A separate record, "Mark Levin" with address state MD, is listed on 5 filings — most recently by Maki Shop Store 3 LLC (Oct 3, 2016). Both records have filings in the same period (Dec 8, 2010 to Oct 3, 2016).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is MA. A separate record, "Mark L Levin" with address state CA, is listed on 4 filings — most recently by Summation Sigma Fund 1, LP (Jun 4, 2012). Both records have filings in the same period (Jan 25, 2010 to Jun 4, 2012).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
The people listed on the Mar 18, 2014 filing give Cambridge, MA; on the Nov 25, 2015 filing they give Bedford, MA.
What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.
The people listed on the Oct 8, 2009 filing give Boston, MA; on the Mar 18, 2014 filing they give Cambridge, MA.
What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.
The people listed on the Apr 15, 2010 filing give Boston, MA; on the Aug 23, 2011 filing they give Cambridge, MA. The address now on file (One Kendall Square, Suite B3501, Cambridge, MA) is a registered-agent or shared-office address used by 16 issuers.
What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.
What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.
1 of 19 offerings reports sales commissions totalling $4,109,999; 0 report finder's fees; 1 reports proceeds to related persons totalling $35,000. (includes amounts the issuer reported as estimates)
| Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it | Source |
|---|---|---|---|---|---|
| Jan 25, 2021 D Corvia Medical, Inc. File 021-387203 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 11, 2020 D Fulcrum Therapeutics, Inc. File 021-368703 | $4,109,999 | $0 | $0 | SVB Leerink LLC BrokerCheck CRD 39011 ↗ | EDGAR ↗ |
| Sep 5, 2018 D Fulcrum Therapeutics, Inc. File 021-320649 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jul 25, 2017 D/A Fulcrum Therapeutics, Inc. File 021-267612 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| May 10, 2017 D Fulcrum Therapeutics, Inc. File 021-286393 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Nov 25, 2015 D NinePoint Medical, Inc. File 021-251996 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Sep 22, 2015 D/A Corvia Medical, Inc. File 021-220190 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Apr 23, 2015 D Voyager Therapeutics, Inc. File 021-238528 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Mar 18, 2014 D NinePoint Medical, Inc. File 021-213827 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Mar 25, 2013 D Third Rock Ventures III, L.P. File 021-193854 | $0 | $0 | $0 (est.) An affiliate of the General Partner will receive a fee for management services. The fee will be a percentage of the aggregate subscriptions of the Issuer's limited partners. | None listed on this filing | EDGAR ↗ |
| Mar 15, 2013 D Corvia Medical, Inc. File 021-193422 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jan 10, 2013 D/A Foundation Medicine, Inc. File 021-184482 | $0 (est.) | $0 (est.) | $0 (est.) | None listed on this filing | EDGAR ↗ |
| Aug 23, 2011 D Foundation Medicine, Inc. File 021-164823 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 6, 2011 D CONSTELLATION PHARMACEUTICALS INC File 021-160851 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Oct 13, 2010 D/A Eleven Biotherapeutics, Inc. File 021-138996 | $0 | $0 | $0 None other than salaries and bonuses in the ordinary course of business. | None listed on this filing | EDGAR ↗ |
| Jun 2, 2010 D CONSTELLATION PHARMACEUTICALS INC File 021-142827 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Apr 15, 2010 D Foundation Medicine, Inc. File 021-140660 | $0 | $0 | $35,000 (est.) | None listed on this filing | EDGAR ↗ |
| Apr 9, 2010 D Third Rock Ventures II, L.P. File 021-140348 | $0 | $0 | $0 (est.) An affiliate of the General Partner will receive a fee for management services. The fee will equal a percentage of the aggregate subscriptions of the Issuer's limited partners. | None listed on this filing | EDGAR ↗ |
| Oct 8, 2009 D NinePoint Medical, Inc. File 021-135073 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
Every issuer that named Mark Levin on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.
Raised $34M from 25 investors (100% of the $13.1M target) as of the latest filing. Mark is listed as director on 4 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $80M from 20 investors (100% of the $68.5M target) as of the latest filing. Mark is listed as director on 5 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $34.6M from 3 investors (85% of the $40.7M target) as of the latest filing. Mark is listed as director, executive officer on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $60M from 10 investors as of the latest filing. Mark is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $500M from 58 investors (100% of the $500M target) as of the latest filing. Mark is listed as executive officer.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Raised $56M from 22 investors (100% of the $56M target) as of the latest filing. Mark is listed as director on 4 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Raised $99M from 30 investors (100% of the $15M target) as of the latest filing. Mark is listed as director on 2 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Raised $20M from 10 investors (57% of the $35M target) as of the latest filing. Mark is listed as executive officer, director on 2 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
No sales reported yet as of the latest filing. Mark is listed as executive officer.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.
Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.
Listed on the same filings as Mark Levin. Their page shows their other deals.
Listed on the same filings as Mark Levin. Their page shows their other deals.
Listed on the same filings as Mark Levin. Their page shows their other deals.
Listed on the same filings as Mark Levin. Their page shows their other deals.
James Geraghty is on 5 issuers in total — a repeat sponsor. Their page lists every one.
Robert Tepper is on 15 issuers in total — a repeat sponsor. Their page lists every one.
Paul LaViolette is on 20 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Mark Levin. Their page shows their other deals.
Gerry Brunk is on 5 issuers in total — a repeat sponsor. Their page lists every one.
Hemant Taneja is on 83 issuers in total — a repeat sponsor. Their page lists every one.
Alexis Borisy is on 16 issuers in total — a repeat sponsor. Their page lists every one.
Russell Hirsch is on 12 issuers in total — a repeat sponsor. Their page lists every one.
David Schenkein is on 5 issuers in total — a repeat sponsor. Their page lists every one.
Michael Pellini is on 6 issuers in total — a repeat sponsor. Their page lists every one.
Noubar Afeyan is on 14 issuers in total — a repeat sponsor. Their page lists every one.
Brook Byers is on 22 issuers in total — a repeat sponsor. Their page lists every one.
David Goeddel is on 20 issuers in total — a repeat sponsor. Their page lists every one.
Mitchell S. Bloom is on 12 issuers in total — a repeat sponsor. Their page lists every one.
Kevin Starr is on 9 issuers in total — a repeat sponsor. Their page lists every one.
David Berry is on 14 issuers in total — a repeat sponsor. Their page lists every one.
Cary Pfeffer is on 9 issuers in total — a repeat sponsor. Their page lists every one.
Garen Bohlin is on 7 issuers in total — a repeat sponsor. Their page lists every one.
Krishna Yeshwant is on 10 issuers in total — a repeat sponsor. Their page lists every one.
Steven Paul is on 6 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Mark Levin. Their page shows their other deals.
One team, 7 deal companies. Mark Levin is listed on 1 of them.
Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Mark Levin.
A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.
Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).
None of the 9 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Property records are matched to companies only, never to individuals, so none are matched to Mark Levin by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 9 issuers this person is listed on — nothing matched.
Websites and social links of the issuers Mark Levin is listed on: none on file. No website or social profile named in Third Rock Ventures III, L.P.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #331,474 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓
One-tap searches on sites we do not index ourselves, with the name pre-filled (Boston, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Mark Levin appears on a new Form D, or when a court case or SEC action is matched to them. See plans →